Document Detail


Audit of the effectiveness of cervical preparation with Dilapan prior to late second-trimester (20-24 weeks) surgical termination of pregnancy.
MedLine Citation:
PMID:  17309543     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this audit was to evaluate the efficacy of cervical preparation with Dilapan dilators prior to late second-trimester surgical termination of pregnancy. The first audit cycle showed that after cervical preparation consisting of one or two Dilapan dilators, with or without misoprostol, on the day before or the day of the procedure, there were nine cases of cervical and uterine damage. The second audit cycle showed that cervical preparation, which consisted of two or three Dilapan dilators, on the day before the procedure improves cervical preparation and reduces the risk of damage to the uterus and cervix.
Authors:
L C Y Poon; J Parsons
Related Documents :
11931683 - Routine cervical cerclage in higher order multiple gestation -- does it prolong the pre...
6954573 - Influence of prostaglandin d2 on the biosynthesis of connective tissue constituents in ...
2362013 - Simultaneous intrauterine and ectopic pregnancies following in-vitro fertilization and ...
Publication Detail:
Type:  Journal Article     Date:  2007-02-19
Journal Detail:
Title:  BJOG : an international journal of obstetrics and gynaecology     Volume:  114     ISSN:  1470-0328     ISO Abbreviation:  BJOG     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-23     Completed Date:  2007-05-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100935741     Medline TA:  BJOG     Country:  England    
Other Details:
Languages:  eng     Pagination:  485-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynaecology, King's College Hospital, London, UK. cylpoon@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Induced / methods*
Adolescent
Adult
Cervical Ripening / physiology*
Dilatation and Curettage / methods
Female
Humans
Medical Audit
Polymers / therapeutic use*
Pregnancy
Pregnancy Trimester, Second
Treatment Outcome
Chemical
Reg. No./Substance:
0/Polymers; 123535-69-3/dilapan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcome of children born out of pregnancies complicated by unexplained polyhydramnios.
Next Document:  Human papillomavirus infection and primary fallopian tube carcinoma: a seroepidemiological study.